argenx SE | ARGX - Ebitda

Prix De L'Action
710.00
Variation Quotidienne
5.00 0.71%
Mensuellement
15.11%
Annuel
35.65%
Q2 Prévisions
666.18




Ebitda Changement Date
AstraZeneca USD 5.23B 272M 2025-09
Galapagos EUR 2.42M 161.13M 2025-09
Genmab DKK 186M 291M 2025-12
GlaxoSmithKline GBP 3.36B 179M 2025-09
GRIFOLS EUR 347.24M 58.35M 2025-06
Hikma Pharmaceutical USD 369M 84M 2024-12
Qiagen NV USD 249.69M 56.53M 2025-12
UCB EUR 1.6B 570M 2025-12